LATEST NEWS

ologen™ Collagen Matrix has been approved by Taiwan Food and Drug Administration (TFDA).

TFDA has officially approved ologen™ Collagen Matrix; this marks another chapter for ologen, along with more than 40 countries which are currently facilitating ologen treatments.

ologen™ Collagen Matrix Implantation is viable to assist Treatment of Scleromalacia after Periocular Surgery.

A long-term study conducted in South Korea with a total of 26 areas of 25 eyes in 25 patients were carried out. Post-operative follow-up of 8-12 months concluded that no eyes showed recurrence or specific complications related to Ologen such as implant extrusion or allergic reaction. Minor complications such as flap vessel engorgement and flap […]

A RETROSPECTIVE STUDY DISCOVERED 41.7% HIGHER RATE OF COMPLETE SUCCESS OF OLOGEN-AUGMENTED AHMED GLAUCOMA VALVE IMPLANTATION THAN CONVENTIONAL METHOD.

This study included a total of 20 eyes of 20 glaucoma patients, who were followed for at least 1-year after undergoing AGV implantation. In 12 eyes of 12 patients, conventional AGV (CAGV) surgery was performed, while in 8 eyes of 8 patients, ologen-augmented AGV (OAGV) implantation was performed. The rate of complete success was significantly […]

Subconjunctival implantation of ologen™ Collagen Matrix to treat ocular hypotony after filtration glaucoma surgery

A Recent 2-year retrospective study shows glaucoma patients in Japan benefiting from the usage of ologen™  collagen matrix in surgery. 7 patients with post-surgery ocular hypotony regained control of their eye pressure and glaucoma medication needs after intervention with collagen matrix assisted bleb revision.

ologen™ CM Patch Grafts Improve Ahmed Valve Treatment Success Rates by 127%

ologen™ CM Patch Grafts Improve Ahmed Valve Treatment Success Rates by 127%   According to a new 6-month Korean study published in the journal Investigative Ophthalmology & Visual Science, success rates of Ahmed Glaucoma Valve (AGV) surgeries soar and post-operative anti-glaucoma medication needs drop when said surgeries are performed in combination with biodegradable collagen patch […]

5-Year MMC vs. ologen™ CM Study finds the latter with 37% Higher Success Rates

5-Year MMC vs. ologen™ CM Study finds the latter with 37% Higher Success Rates   A new study published in the Journal of Ophthalmology in May finds that using collagen matrix implants (available commercially as ologen™ CM) in place of mitomycin C (MMC) can significantly increase the long-term (5 year) success rates of open-angle glaucoma […]

A meta-analysis on ologen™ Collagen Matrix vs MMC in Trabeculectomy to be highlighted at the 2014 AGS Exhibit

A meta-analysis on ologen™ Collagen Matrix vs MMC in Trabeculectomy to be highlighted at the 2014 AGS Exhibit A meta-analysis on ologen™ Collagen Matrix vs. MMC in trabeculectomy by Miao He et al. (2014) will be highlighted during the exhibit of AAE at the 2014 AGS, Washington DC at Omni Shoreham Hotel from Feb 27 – Mar […]

New Horizons: “Novel Applications for ologen™ Collagen Matrix” at the 5th WGC, July 2013, Vancouver, Canada

New Horizons: “Novel Applications for ologen™ Collagen Matrix” at the 5th WGC, July 2013, Vancouver, Canada The Aeon Astron sponsored symposium “New Horizons: Novel Applications for ologen™ Collagen Matrix” held at the fifth World Glaucoma Congress, Vancouver, met with great success. The symposium featured the US experience with ologen™ Collagen Matrix (Dr David Godfrey, Glaucoma […]

India as leading country in the application of ologen™ Collagen Matrix and its combined use

India as leading country in the application of ologen™ Collagen Matrix and its combined use 2013 APAO-AIOS symposia recognize India as leading country in the application of ologen™ Collagen Matrix and its combined use with other compounds. The Aeon Astron sponsored symposium at the 2013 APAO-AIOS Joint Congress1 “Breakfast Debate: ologen™ Collagen Matrix or MMC for Glaucoma […]

EuroTimes And EyeWorld News on ologen™ Collagen Matrix

EuroTimes And EyeWorld News on ologen™ Collagen Matrix   ologen™ Collagen Matrix as An Alternative to MMC And The Patch Grafts in Glaucoma Surgery The monthly magazine of ESCRS1, EuroTimes (Vol 17; 11, Nov 2012), and the official news magazine of ASCRS2, EyeWorld (Vol 17; 9, Sept 2012), cover the news on ologen™ Collagen Matrix […]

Expansive applications of ologen™ Collagen Matrix in eye tissue repair and grafting widely discussed at 2012 EGS

Expansive applications of ologen™ Collagen Matrix in eye tissue repair and grafting widely discussed at 2012 EGS At the 10th European Glaucoma Society Congress in Copenhagen (June 17 – 22, 2012 ), Prof. T.S. Dietlein (Germany) and Dr. Hans J. Schuitmaker (The Netherlands) called for the need of ready-to-use anti-fibrotics and tissue repair grafting in […]

AAE successfully held speaker forums at APAO 2012 Busan

AAE successfully held speaker forums at APAO 2012 Busan We have successfully held six sessions of ologen™ speaker forum at APAO Busan, with a total of over 150 attendees from 4/13~ 4/15. The slides of the speaker forum are available upon request: Dr. Lee- ologen™ in repair of sclera thinning with autograft (video) Dr. Rakib- ologen™ in […]

AAE Holds Successful ologen™ Symposium at WOC 2012

AAE Holds Successful ologen™ Symposium at WOC 2012     Aeon Astron Europe B.V. (AAE) successfully held symposium entitled “A Replacement for MMC? – ologen™ Collagen Matrix for Tissue Repair” in World Ophthalmology Congress (WOC) 2012 at Abu Dhabi, United Arab Emirates in Feb-19-2012 (Sunday), 09:00~10:15 am. ologen™ Collagen Matrix was showcased as an potential alternative to Mitomycin […]

Can MMC be replaced? ologen™ Collagen Matrix for Eye Tissue Repair

Can MMC be replaced? ologen™ Collagen Matrix for Eye Tissue Repair ologen™ Symposium held at the World Glaucoma Congress. July 1st, Room 341, Palais des Congrès, Paris. Scientific Program: Can MMC be replaced? ologen™ Collagen Matrix for Eye Tissue Repair Moderated by Mr. Michael Lai. CEO, Aeon Astron Europe Dr. Julio Lin, Aeon Astron Europe […]

Membership of WGA

Membership of WGA   Aeon Astron Europe B.V. becomes the Glaucoma Industry member of WGA. Related Link :http://www.worldglaucoma.org/